首頁 > 市場調查報告書 > 醫療設備

病患監測血糖監測

市場調查報告書

商品編碼

1624431

2024 年至 2031 年血糖儀市場（依產品、技術、通路和地區劃分）

Glucometer Market By Product (Continuous Glucose Monitoring Devices, Self-Monitoring Blood Glucose (SMBG) Systems), Technique (Invasive, Non-invasive), Distribution Channel (Hospital, Retail, Online), And Region for 2024-2031

出版日期: 2024年11月18日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年至 2031 年血糖機市場評估

透過補貼、保險覆蓋和公共衛生計劃增加獲得糖尿病護理和管理設備（如血糖儀）的機會是市場擴張的主要驅動力。據 Verified Market Research 分析師稱，血糖儀市場規模預計將從 2024 年的約 106.8 億美元下降到 2031 年預測期內的 243.8 億美元。

由於人口老化、久坐的生活方式和肥胖率上升等因素，全球糖尿病患者數量不斷增加，大大推動了對血糖測量設備的需求。這將使市場從 2024 年到 2031 年的複合年增長率達到 10.87%。

血糖儀市場定義/概述

血糖儀，也稱為血糖儀，是一種用於測量和監測血液中葡萄糖濃度的便攜式醫療設備。血糖監測儀主要由糖尿病患者使用，在管理血糖水平方面發揮至關重要的作用，這對於有效控製糖尿病至關重要。該設備通常由一個帶有數位顯示器的小型手持裝置和一個用於刺穿皮膚獲取血液樣本的刺血針組成。使用者將一滴血液放在一次性試紙上，然後將其插入血糖儀中。

血糖儀分析血液樣本並顯示血糖值的數值讀數，通常以毫克每分升 (mg/dL) 或毫摩爾每公升 (mmol/L) 表示。定期使用血糖儀監測可以對飲食、藥物和生活方式做出明智的決定，最終有助於維持最佳血糖控制並預防糖尿病相關併發症，有助於降低疾病風險。

糖尿病盛行率的上升將如何影響血糖儀市場的成長？

糖尿病盛行率的不斷上升將對有效血糖監測解決方案的需求產生更大的影響，從而顯著影響血糖儀市場的成長。根據國際糖尿病聯盟的數據，2021年將有約5.37億成年人罹患糖尿病，預計2030年這一數字將增加至6.43億，到2045年將增加至7.83億。糖尿病患者數量的增加凸顯了對血糖儀的迫切需求，因為定期監測對於控制血糖水平和預防糖尿病相關併發症至關重要。

此外，政府措施支持的糖尿病管理意識不斷增強以及自我監測實踐的重要性進一步推動了市場需求。光是 2021 年，糖尿病就將導致全球約 670 萬人死亡，凸顯了對可用監測工具的迫切需求。

此外，持續血糖監測系統的發展等技術進步使得這些設備更加用戶友好、更具吸引力，進一步促進了市場的擴大。

血糖機市場製造商面臨的主要技術課題是什麼？

血糖儀市場的製造商面臨著多項技術課題，這些課題影響了他們跟上創新和不斷增長的消費者需求的能力。主要課題之一是需要提高血糖測量的準確性和可靠性。儘管取得了進步，但血糖儀讀數和實際血糖水平之間仍可能存在差異，這可能導致糖尿病管理不善。根據國際糖尿病聯盟的數據，糖尿病將導致 2021 年約 670 萬人死亡，凸顯了對精準監測工具的迫切需求，以防止此類後果。

此外，法規遵循是一個主要障礙。血糖儀被歸類為醫療設備，因此必須遵守美國食品藥物管理局 (FDA) 等機構制定的嚴格規定。這個合規過程既耗時又昂貴，常常會延遲產品發佈和創新。另一個課題是來自替代監測方法的競爭，例如持續血糖監測 (CGM) 系統，它可以提供即時數據而無需頻繁刺穿手指。隨著CGM技術越來越普及，傳統血糖儀製造商必須投入研發來增強其產品並維持市場佔有率。

此外，先進的血糖儀技術價格昂貴，這可能會限制其可及性，特別是在糖尿病盛行率不斷上升的中低收入國家。這些綜合的技術課題意味著，為了有效管理糖尿病，製造商必須在適應監管環境和應對市場競爭的同時不斷創新。

Enhance access to diabetes care and management instruments, such as glucometers, via subsidies, insurance coverage, and public health programmes, are critical drivers of market expansion. According to the analyst from Verified Market Research, the Glucometer Market is estimated to reach a valuation of USD 24.38 Billion over the forecast period 2031, by subjugating around USD 10.68 Billion valued in 2024.

The global increase in diabetes cases, caused by factors such as ageing populations, sedentary lifestyles, and rising obesity rates, is significantly driving up demand for glucometers. It enables the market to grow at a CAGR of 10.87% from 2024 to 2031.

Glucometer Market: Definition/ Overview

A glucometer, also known as a blood glucose meter, is a portable medical device designed to measure and monitor the concentration of glucose in a person's blood. Primarily used by individuals with diabetes, glucometers play a crucial role in managing blood glucose levels, which is essential for effective diabetes control. The device typically consists of a small handheld unit with a digital display, along with a lancet for pricking the skin to obtain a blood sample. Users place a drop of blood on a disposable test strip, which is then inserted into the glucometer.

Glucometer analyzes the blood sample and provides a numerical reading of the blood glucose level, usually expressed in milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L). Regular monitoring with a glucometer enables individuals to make informed decisions about their diet, medication, and lifestyle, ultimately helping to maintain optimal blood sugar control and reduce the risk of diabetes-related complications.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

How does the Increasing Prevalence of Diabetes Influence the Growth of the Glucometer Market?

The increasing prevalence of diabetes significantly influences the growth of the glucometer market by creating a larger demand for effective blood glucose monitoring solutions. According to the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021, a figure projected to rise to 643 million by 2030 and further to 783 million by 2045. This escalating number of diabetes cases highlights the urgent need for glucometers, as regular monitoring is crucial for managing blood sugar levels and preventing complications associated with the disease.

Moreover, the growing awareness of diabetes management and the importance of self-monitoring practices, supported by government initiatives, further drive market demand. In 2021 alone, diabetes was responsible for approximately 6.7 million deaths worldwide, emphasizing the critical need for accessible monitoring tools.

Additionally, advancements in technology, such as the development of continuous glucose monitoring systems, are making these devices more user-friendly and appealing, further contributing to market expansion.

What are the Main Technological Challenges Faced by Manufacturers in the Glucometer Market?

Manufacturers in the glucometer market face several technological challenges that impact their ability to innovate and meet growing consumer demands. One of the primary challenges is the need for enhanced accuracy and reliability in glucose measurements. Despite advancements, discrepancies between glucometer readings and actual blood glucose levels can occur, leading to potential mismanagement of diabetes. According to the International Diabetes Federation, diabetes resulted in approximately 6.7 million deaths in 2021, underscoring the critical need for precise monitoring tools to prevent such outcomes.

Additionally, regulatory compliance poses a significant hurdle. Glucometers are classified as medical devices, which means they must adhere to stringent regulations set forth by authorities like the U.S. Food and Drug Administration (FDA). This compliance process can be time-consuming and costly, often delaying product launches and innovations. Another challenge is the competition from alternative monitoring methods, such as continuous glucose monitoring (CGM) systems, which provide real-time data without the need for frequent finger pricking. As CGM technology gains popularity, traditional glucometer manufacturers must invest in research and development to enhance their offerings and retain market share.

Furthermore, the high cost of advanced glucometer technologies can limit accessibility, particularly in low- and middle-income countries where diabetes prevalence is rising. The combination of these technological challenges requires manufacturers to continuously innovate while navigating regulatory landscapes and addressing market competition to ensure the effective management of diabetes.

Category-Wise Acumens

What Factors Contribute to the Dominance of Self-monitoring Blood Glucose (SMBG) Systems in the Glucometer Market?

The dominance of self-monitoring blood glucose (SMBG) systems in the glucometer market can be attributed to several key factors. Firstly, the rising prevalence of diabetes significantly drives demand for these devices. According to the Centers for Disease Control and Prevention (CDC), approximately 11.6% of the U.S. population, equating to about 38.4 million individuals, were affected by diabetes in 2021. This growing patient base necessitates effective monitoring solutions to manage blood glucose levels effectively and prevent complications associated with the disease.

Additionally, advancements in technology have made SMBG systems more accurate, user-friendly, and accessible. Features such as Bluetooth connectivity, integration with mobile health applications, and improved test strip designs enhance the overall user experience, encouraging more individuals to engage in regular monitoring. Furthermore, supportive government initiatives and reimbursement policies for SMBG devices in many regions promote their adoption, making them more financially accessible to patients.

The shift towards home-based healthcare, accelerated by the COVID-19 pandemic, has also bolstered the SMBG market, as patients increasingly prefer the convenience of monitoring their blood glucose levels at home rather than frequent hospital visits.

How does the Cost-Effectiveness of Invasive Glucometers Contribute to their Market Dominance?

The cost-effectiveness of invasive glucometers significantly contributes to their dominance in the glucometer market by making them accessible to a broader range of consumers, particularly those managing diabetes. Invasive glucometers, which typically involve finger-pricking to obtain blood samples, are regarded as the gold standard for blood glucose monitoring due to their accuracy and reliability. The American Diabetes Association and the International Diabetes Federation recommend these devices for effective diabetes management, reinforcing their credibility among healthcare providers and patients alike.

Government statistics further highlight the importance of cost-effectiveness in this market. For instance, the Centers for Disease Control and Prevention (CDC) reported that approximately 11.6% of the U.S. population, or about 38.4 million individuals, were living with diabetes in 2021. As the demand for affordable and reliable monitoring solutions rises, invasive glucometers remain a preferred choice due to their relatively low initial costs compared to newer technologies like continuous glucose monitoring systems.

Moreover, the widespread availability of test strips and lancets, which are essential consumables for invasive glucometers, helps maintain their affordability. The combination of these factors ensures that invasive glucometers continue to dominate the market, as they provide a cost-effective solution for millions of individuals needing regular blood glucose monitoring to manage their diabetes effectively.

Country/Region-wise Acumens

What Factors are Driving Asia Pacific's Dominance in the Glucometer Market?

Asia Pacific's dominance in the glucometer market is driven by several key factors, primarily the rising prevalence of diabetes and increasing healthcare investments. The International Diabetes Federation reported that over 206 million adults in the Asia Pacific region were living with diabetes in 2021, a number projected to rise to 238 million by 2030. This alarming trend necessitates effective blood glucose monitoring solutions, leading to heightened demand for glucometers.

Additionally, the region has seen significant government initiatives aimed at improving diabetes management and healthcare infrastructure. Furthermore, increasing awareness about diabetes and its management among patients and healthcare providers is driving the adoption of self-monitoring blood glucose devices. The accessibility of advanced technologies, such as continuous glucose monitoring systems, is also enhancing the market landscape. Collectively, these factors position Asia Pacific as a rapidly expanding market for glucometers, with a strong outlook for continued growth in the coming years.

What Factors are Driving the Continuous Growth of the Glucometer Market in North America?

The glucometer market in North America is experiencing continuous growth driven by several key factors. One of the primary drivers is the increasing prevalence of diabetes in the region. According to the Centers for Disease Control and Prevention (CDC), approximately 37.3 million people in the United States had diabetes in 2021, representing 11.3% of the population. This alarming statistic highlights the urgent need for effective blood glucose monitoring solutions, which is fueling the demand for glucometers.

Technological advancements in glucometer design and functionality are also driving the market's expansion. The development of compact, user-friendly devices with improved accuracy and connectivity features, such as Bluetooth integration and mobile app integration, is making glucometers more appealing to patients and healthcare providers alike. These innovations are enhancing the overall user experience and encouraging more individuals to engage in regular blood glucose monitoring.

Furthermore, the growing awareness of the importance of diabetes management and the availability of educational resources are contributing to the market's growth. As patients and healthcare providers become more informed about the significance of regular blood glucose monitoring in preventing complications and improving overall health outcomes, the demand for glucometers is expected to continue rising.

Competitive Landscape

The Glucometer Market is characterized by fierce competition among participants, which is driven by technological advancements, accuracy, and user-friendliness. Other essential variables that organizations consider while establishing and maintaining their market presence include price competitiveness, product differentiation, and worldwide expansion.

Some of the prominent players operating in the glucometer market include:

Abbott Diabetes Care

Roche Diagnostics

Medtronic

Dexcom

LifeScan

Ascensia Diabetes Care

Ypsomed

Braun

Nipro

Sanofi

Arkray

Prodigy Diabetes Care

Acon Laboratories

Nova Biomedical

Terumo

Latest Developments

In October 2023, Abbott launched the FreeStyle Libre 3 system in Canada, which is designed to provide real-time glucose readings with a smaller, more discreet sensor that offers improved accuracy and comfort for users.

In September 2023, Roche launched the Accu-Chek Instant, a new glucometer designed to provide users with instant feedback on their blood glucose levels. This device features a user-friendly interface and offers advanced connectivity options, allowing users to track their glucose levels more efficiently through a mobile app.

1 INTRODUCTION OF GLOBAL GLUCOMETER MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL GLUCOMETER MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL GLUCOMETER MARKET, BY PRODUCT

5.1 Overview
5.2 Continuous Glucose Monitoring Devices
5.3 Self-Monitoring Blood Glucose (SMBG) Systems

6 GLOBAL GLUCOMETER MARKET, BY TECHNIQUE

6.1 Overview
6.2 Invasive
6.3 Non-invasive

7 GLOBAL GLUCOMETER MARKET, BY DISTRIBUTION CHANNEL

7.1 Overview
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies
7.5 Others

8 GLOBAL GLUCOMETER MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL GLUCOMETER MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES

10.1 Abbott Diabetes Care
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Roche Diagnostics
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Medtronic
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Dexcom
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 LifeScan
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 Ascensia Diabetes Care
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 Ypsomed
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 B. Braun
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Nipro
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 Sanofi
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments